176 related articles for article (PubMed ID: 37336590)
1. Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa.
Naicker SD; Shuping L; Zulu TG; Mpembe RS; Mhlanga M; Tsotetsi EM; Maphanga TG; Govender NP;
Med Mycol; 2023 Jun; 61(6):. PubMed ID: 37336590
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
Al-Baqsami ZF; Ahmad S; Khan Z
Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
[TBL] [Abstract][Full Text] [Related]
4. Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure.
Arastehfar A; Daneshnia F; Salehi M; Yaşar M; Hoşbul T; Ilkit M; Pan W; Hagen F; Arslan N; Türk-Dağı H; Hilmioğlu-Polat S; Perlin DS; Lass-Flörl C
Mycoses; 2020 Sep; 63(9):911-920. PubMed ID: 32413170
[TBL] [Abstract][Full Text] [Related]
5. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
6. Changing epidemiology of candidaemia in Australia.
Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S;
J Antimicrob Chemother; 2017 Apr; 72(4):1103-1108. PubMed ID: 28364558
[TBL] [Abstract][Full Text] [Related]
7. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.
Pfaller MA; Castanheira M; Lockhart SR; Ahlquist AM; Messer SA; Jones RN
J Clin Microbiol; 2012 Apr; 50(4):1199-203. PubMed ID: 22278842
[TBL] [Abstract][Full Text] [Related]
8. Antifungal resistance in patients with Candidaemia: a retrospective cohort study.
Aldardeer NF; Albar H; Al-Attas M; Eldali A; Qutub M; Hassanien A; Alraddadi B
BMC Infect Dis; 2020 Jan; 20(1):55. PubMed ID: 31952505
[TBL] [Abstract][Full Text] [Related]
9. Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial
Misas E; Seagle E; Jenkins EN; Rajeev M; Hurst S; Nunnally NS; Bentz ML; Lyman MM; Berkow E; Harrison LH; Schaffner W; Markus TM; Pierce R; Farley MM; Chow NA; Lockhart SR; Litvintseva AP
J Clin Microbiol; 2024 Feb; 62(2):e0114023. PubMed ID: 38265207
[No Abstract] [Full Text] [Related]
10. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
[TBL] [Abstract][Full Text] [Related]
11. Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.
Pham CD; Iqbal N; Bolden CB; Kuykendall RJ; Harrison LH; Farley MM; Schaffner W; Beldavs ZG; Chiller TM; Park BJ; Cleveland AA; Lockhart SR
Antimicrob Agents Chemother; 2014 Aug; 58(8):4690-6. PubMed ID: 24890592
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for isolation of fluconazole and echinocandin non-susceptible
Papadimitriou-Olivgeris M; Spiliopoulou A; Fligou F; Tsiata E; Kolonitsiou F; Nikolopoulou A; Papamichail C; Spiliopoulou I; Marangos M; Christofidou M
J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34431765
[No Abstract] [Full Text] [Related]
13. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.
Shah DN; Yau R; Weston J; Lasco TM; Salazar M; Palmer HR; Garey KW
J Antimicrob Chemother; 2011 Sep; 66(9):2146-51. PubMed ID: 21700622
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia.
Dunaiski CM; Kock MM; Chan WY; Ismail A; Peters RPH
Med Mycol; 2024 Jan; 62(2):. PubMed ID: 38308518
[TBL] [Abstract][Full Text] [Related]
16. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
Doğan Ö; Yeşilkaya A; Menekşe Ş; Güler Ö; Karakoç Ç; Çınar G; Kapmaz M; Aydın M; Keske Ş; Şahin S; Hacıseyitoğlu D; Yalçın D; Tekin S; Ataç N; Albayrak Ö; Aksu ED; Can F; Ergönül Ö
Int J Antimicrob Agents; 2020 Jul; 56(1):105992. PubMed ID: 32335275
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
[TBL] [Abstract][Full Text] [Related]
18. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
19. Candidemia surveillance in Iowa: emergence of echinocandin resistance.
Matsumoto E; Boyken L; Tendolkar S; McDanel J; Castanheira M; Pfaller M; Diekema D
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):205-8. PubMed ID: 24666704
[TBL] [Abstract][Full Text] [Related]
20. Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates.
Díaz-García J; Machado M; Alcalá L; Reigadas E; Sánchez-Carrillo C; Pérez-Ayala A; Gómez-García de la Pedrosa E; González-Romo F; Merino P; Cuétara MS; García-Esteban C; Quiles-Melero I; Zurita ND; Muñoz-Algarra M; Durán-Valle MT; Martínez-Quintero GA; Sánchez-García A; Muñoz P; Escribano P; Guinea J;
Clin Microbiol Infect; 2023 Dec; 29(12):1604.e1-1604.e6. PubMed ID: 37640239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
